Objective To evaluate factors affecting unselected populationbased BRCA testing in Ashkenazi Jews (AJ).
Introduction
Unselected population-based Founder Mutation BRCA testing in the Ashkenazi Jewish (AJ) population has been investigated in the UK Genetic Cancer-Prediction through a Population-Screening (GCaPPS) randomised controlled trial (RCT) (ISRCTN73338115), 1 as well as in Israeli 2 and Canadian 3 single-arm cohort studies. The GCaPPS trial offered pre-test counselling outside a hospital in a highstreet/community-based setting. Traditional face-to-face and DVD-based approaches were compared and found to be equivalent. 4 The Israeli/Canadian studies provided only post-test counselling to mutation carriers or those with a strong family history (FH) of cancer. High satisfaction rates have been reported in all three studies. 1, [4] [5] [6] A populationbased approach identifies >50% additional BRCA-carriers compared with clinical criteria/FH-based testing, does not detrimentally affect psychological well-being or quality-oflife on a population basis, 1, 5 and has been found to be extremely cost-effective. 7 This has led to calls by a number of experts for changing the paradigm to population-based BRCA testing in the AJ population. 8, 9 Only limited data exist on attitude and factors affecting uptake of population-based BRCA testing in the Jewish population, and these are largely restricted to women. 5, 10 Differences have also been reported between those who are selfreferred and those recruited through clinical services. 5 The Jewish population is the first population for whom population-based BRCA testing is likely to become a reality. Understanding attitudes and factors affecting uptake are essential to help in the planning of clinical services, supportive care/ interventions and future genetic testing programmes. In this paper we describe the attitudes towards and factors affecting uptake as well as interest in and intention-to-access population-based BRCA testing among AJ women and men.
Methods
GCaPPS participants were recruited from the North London Jewish community. Recruitment was based on self-referral. 1 Study flyers were made available through community charities, a high-street pharmacy (Boots), select GP practices and a website. Inclusion and exclusion criteria have been described earlier. 1 Individuals expressing an interest registered with the study team and were sent a detailed trial information booklet. Pre-test counselling was undertaken through six high-street/ community-based centres in London. 1 Recruitment clinics (clusters) were randomised to traditional face-to-face and DVD-counselling approaches between 2009 and 2010, the outcomes of which have been reported earlier. 4 We report on data from individuals who underwent pre-test counselling in recruitment clinic clusters. Genetic-counselling was undertaken by a qualified genetics counsellor and a clinical fellow experienced in risk assessment and management of cancer genetics. The counselling covered FH, cancer risk, genetic inheritance, risk management, psychosocial implications, and advantages/ disadvantages in order to meet counselling goals [11] [12] [13] and enable informed choice and adaptation. Individuals opting for genetic testing provided a blood sample for the three AJ BRCA founder-mutations: 185delAG(c.68_69delAG), 5382insC(c.5266dupC), and 6174delT(c.5946delT).
A baseline questionnaire assessed socio-demographic characteristics and FH. Knowledge was assessed by a specially developed 10-item (True = 1/False = 0) questionnaire described earlier. 4 Anxiety/depression was assessed by the Hospital Anxiety and Depression scale (HADS).
14 Attitude towards BRCA testing was assessed by an 18-item questionnaire (Supporting Information Appendix S1): 1) seven items assessing perceived benefits (to be reassured, enhance cancer prevention, learn about my children's risk, make a decision about preventive surgery, make childbearing decisions, know if I need to get cancer screening, reduce uncertainty); 2) seven items assessing perceived limitations/risks (worried about insurance, loss of confidentiality, stigmatisation, don't trust modern medicine, nothing can be done to prevent cancer, concerned about impact on family, unable to handle it emotionally); 3) four items assessing cultural/religious influences (too focused on Jewish community, marriage ability, singling out individuals of a particular ethnic group, altruism). A Likert scale assessed the level of importance participants attached to each of these items (1 = not at all important, 2 = somewhat important, 3 = very important; or 1 = definitely not, 2 = somewhat and 3 = definitely). The 14 items in sections (i) and (ii) were taken from Lerman 15, 16 and have been used by others. 17, 18 Items in section (iii) were adapted from Phillips 19 & Andrews.
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Uptake of testing was calculated by the proportion of individuals who underwent BRCA testing following pre-test counselling. Initial pre-counselling 'interest' in undergoing testing was measured with: 'If it were available to you now, would you, in the next 6 months, have a BRCA test to see if you are at risk of developing cancer in the future?' Response options were : 'yes-definitely'/'yes-probably'/'no-probably not'/'no-definitely not'. This item was adapted from previous research (Sanderson) , [21] [22] [23] and was chosen on the basis that the 6-month time frame made the hypothetical question more concrete and is about as far into the future as most people plan a specific change in behaviour. 24 Pre-counselling 'intention-to-take' the BRCA test was assessed with an item adapted from Lerman 15 and Schwartz 18 : At the present time, which of the following statements describes you best? Response options: Haven't thought about it/not considering BRCA testing; Considering BRCA testing; Probably will have BRCA testing; Definitely will have BRCA testing.
Statistical analysis
Baseline characteristics were calculated using descriptive statistics.
Interest, intention and uptake of BRCA testing Socio-demographic factors of interest and their relations with (i) interest in BRCA testing, (ii) intention to undergo BRCA testing, and (iii) uptake of BRCA testing were explored in logistic-regression models in both univariable and multivariable settings. Specifically, (i) and (ii) used an ordinal regression-model as the outcome variables contained four clearly ordered options (listed above), whereas the uptake model used binary logistic regression (Acceptor/ Decliner). All models were regressed on the factors: gender (men versus women), marital status (married/cohabiting versus widowed/divorced/single), income (£10,000 to < £20,000, £20,000 to <£30,000, £30,000 to <£40,000, £40,000 to <£50,000 and >£50,000 versus <£10,000), education (degree level/above versus no formal qualification/ GCSE/O-level/CSE/NVQ1/NVQ2/A-level education), family history (low-risk versus high-risk), having children (yes versus no), age, HAD score, cancer-risk perception scale and a BRCA-knowledge score. Statistical inference was based on cluster robust standard errors, with the cluster based on counselling clinics. Joint Wald tests were used to test the joint significance of more than one parameter.
Attitudes to BRCA testing-Item Response Theory
The Item Response Theory (IRT) was used to model responses of the 935 volunteers to the 18 items (covering positive reasoning/negative reasoning/cultural issues) regarding attitudes to BRCA testing. IRT is a unified methodology for measuring of both individuals in terms of an unobserved latent trait ('ability') and the items themselves from the administered instrument on the same metric. Statistical models are used to relate the responses to the items in terms of the item 'difficulty' and the item 'discrimination'. Difficulty reflects the location of the item on the continuous trait, specifically the point where the item is successfully responded to with 50% probability. Discrimination reflects the steepness of the S-shaped (logistic) curve, i.e. how quickly the probability of 'success' changes with ability values near the item difficulty. A steeper item implies an item better able to discriminate between individuals closely placed on the continuum. Advantages of IRT over more common and simplistic methods of scoring include: the allowance for missing data-the latent value is estimated simply on the items that have been answered, and so is not generally testdependent; the ability to compare item and individual simultaneously; and the characterisation of statistical uncertainty regarding parameters and scores.
In IRT the items are modelled by a collective set of logistic-regression type models. However, the items are 'regressed' on the latent trait which is unobserved. Hence, the trait is assumed to be (standard) normally distributed and marginal maximum-likelihood estimation is used, with the assumed latent distribution integrated out. Because the items used in the (attitude to BRCA testing) scale each have multiple responses in a naturally ordered manner (Not at all important/Somewhat important/Very important) we have used the graded response model (GRM) for each item, analogous to ordered logistic-regression. For each item category boundary, there is a difficulty estimate (between 'Not at all important/Somewhat important' and between 'Somewhat important/Very important') and a single discrimination parameter for each of the 18 items. Graphical methods used to display the GRM include: boundary characteristic curves (BCCs-where the next category becomes more likely), category characteristic curves (CCCs-the probability of response for each item category along the continuum), individual and overall item information functions (IIFs-showing the amount of statistical information reflected by the item or the scale as a whole, respectively), and the density plot of the scores. Attitudes to testing scores for each individual based on their response pattern were calculated marginally by integrating over the latent trait distribution and using the posterior mean. The distribution of scores was investigated with a kernel density plot. The association of socio-demographic factors with the GRM attitude to testing scores was also explored with multivariable linear regression.
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Core outcome sets (COS)
There are no core outcome sets for population or BRCA testing at present.
Patient and public involvement (PPI)
The research team undertook an extensive community engagement exercise prior to commencement of the study. This included meetings with decision-makers, Rabbis, the Jewish Medical Association, numerous Jewish Charities and stakeholders across all sections of the Jewish community (e.g. Orthodox, Liberal, Reform, Masorti and Unaffiliated). This was essential to understand the perspectives of all community stakeholders, address concerns, ensure stakeholder management, increase engagement and awareness, as well as facilitate development and delivery of study. PPI stakeholders contributed to the development and design of study materials, provided representation on the Trial Steering committee and also provided community-based premises for conduct of the study. Supporting charities and organisations helped increase awareness of the study by organising workshops, meetings and newsletters. Feedback received highlighted the importance of having communitybased, easily accessible centres for counselling (non-hospital settings) to promote anonymity and easy access. Charities-Jewish Care, Norwood, Agudas Israeli Housing Association provided premises for pre-and post-test counselling. Input into patient-facing document design helped highlight sensitive issues around testing and avoid anything the public may find insensitive or potentially offensive. The study title was also modified following feedback from the community. A cooling off period of 2 weeks was introduced to enable withdrawal in case people changed their minds. This PPI exercise was critical for the success of the study. BRCA testing is a sensitive issue and can lead to a range of opinions and emotions. It highlighted issues of concern in the community which were addressed by the study team prior to commencement of the study and also provided an opportunity for engagement to reassure stakeholders on the structure and governance around the study as well as the necessity and commitment to informed consent. 
Results
Overall, 935 people underwent pre-test genetic-counselling in recruitment clinic clusters (256 clusters, mean cluster size = 3.64) in the GCaPPS study. The mean age of participants was 53.8 (SD = 15.02) years. Table 1 describes the baseline characteristics of the cohort. Pre-counselling levels of 'interest' were much higher than levels of any clear 'intention' to undergo BRCA testing (Table 1) . While 96% expressed interest, only 60% indicated a clear intention to undergo BRCA testing pre-counselling. Overall, 88% subsequently opted for BRCA testing. Of these, 67% were women (33% men), 59% had a degree or higher level of education, and 79% were married/cohabiting. The association of socio-demographic variables with uptake, intention, and interest in BRCA testing observed on uni-variable and multi-variable logistic-regression analyses is described in Table 2 . Increased cancer risk perception was significantly associated with higher levels of interest in testing (P = 0.017). Higher education level was associated with reduced intention-to-test (P = 0.033). However, higher levels of BRCA-related knowledge were associated with increased interest (P = 0.012), intention-to-test (P = 0.003) as well as increased uptake of BRCA testing (P = 0.002). Increased anxiety (anxiety HADS P = 0.009; total HADS P = 0.016) was associated with reduced uptake of BRCA testing. Multivariable modelling confirmed that knowledge (P = 0.013) and education (P = 0.01) remained significantly associated with intention-to-test, and being married or cohabiting was associated with four-fold higher odds of uptake of BRCA testing (P = 0.009) ( Table 2) . We did not find a statistically significant association of FH, gender, income or age with uptake/intention/interest in BRCA testing. The association of perceived benefits, risks, and cultural factors with uptake of BRCA testing as well as prior 'intention-to-test' and 'interest' in BRCA testing are given in Table 3 . The various perceived benefits of BRCA testing were significantly associated with higher pre-counselling odds of interest in and intention to undergo BRCA testing but not with actual uptake of testing (except to make childbearing decisions) ( Table 3 ). The risks associated with insurance, confidentiality, emotional impact, inability to prevent cancer/lack of trust in modern medicine, were negatively associated with interest but were not associated with intention to undergo testing. However, increased importance attached to all the risks/limitations was significantly associated with lower odds of uptake of BRCA testing (Table 3) . Increased levels of concern associated with focus on the Jewish ethnic community, singling out an ethnic group and marriage ability were associated with significantly lower interest/intention and lower odds of uptake of BRCA testing. Altruism did not affect intention or uptake of BRCA testing (c Table S1 ).
The individual item information functions (IIFs), showing the amount of statistical information reflected by each item of the scale, is given in Supporting Information Figure S1 . It suggests that reduction in uncertainty and reassurance were the most important of all factors associated with BRCA testing. The category characteristic curves for the GRM are given in Supporting Information Figure S2 and the boundary characteristic curves (BCCs) are given in Supporting Information Figure S3 . The density plot of the scores had a normal distribution and is given in Supporting Information Figure S4 . Table 4 shows the association of socio-demographic variables with the overall GRM attitude to testing (benefits/risks/cultural factors) scores. Men (P = 0.001) and those with higher education (P = 0.001) had lower attitude scores, whereas those with children had higher scores (P = 0.005) associated with BRCA testing.
Discussion

Main findings
We found a high uptake of BRCA testing (88%) reconfirming the broad acceptability/support for BRCA testing in the AJ population. The apparent benefits of cancer prevention, screening, reassurance, information about children's risk, and reduction in uncertainty were major motivators for BRCA testing. However, it was the perceived disadvantages and cultural factors (not benefits) that were statistically significantly associated with final 'uptake' (lower odds) of BRCA testing and differentiated 'acceptors' from 'decliners'. Marriage ability, ethnic focus, stigmatisation, confidentiality, insurance, and emotional impact were concerns for some participants and were associated with lower odds of undergoing BRCA testing. Pre-test counselling enabled informed decision-making on uptake of testing. People with stronger attitudes towards BRCA testing included women, those with less than degree-level education, and those with children. However, individuals with a PhD/Masters/Bachelors' degree had weaker attitudes and lower levels of initial 'intention' than those with lower/no qualifications
Strengths and limitations
Strengths of our study include its population-based ascertainment, pre-test counselling for all, and presence of women and male participants. Our study population is likely to represent a good estimate and distribution of the characteristics of people who may come forward for population-based BRCA testing should it be offered in the future. A limitation is lack of qualitative data on factors affecting attitude/uptake on BRCA testing. Nevertheless, a number of our findings are consistent with qualitative data reported by others. 10 
Interpretation
Our findings of BRCA testing acceptability are consistent with reports from Israel and Canada. 3, 5, 10 Our uptake was slightly higher than the 67% reported in the Israeli study. 5 This could be due to population differences or recruitment location. Uptake rates appear to be higher when testing services are delivered in the community. Uptake rates reported in ambulatory clinics in the Israeli study were similar to ours. An extensive community engagement exercise undertaken during the study development highlighted the importance of providing testing within the community outside a hospital environment, and facilitated uptake. Additionally our study included standardised pre-test counselling.
Motivators for BRCA testing observed by us have also been reported in the Israeli population-testing study, 10 telephone surveys, 17, 25 and interviews with high-risk AJ women. 19 Although potential discrimination concerns some people, this is not widespread in the majority of the population. Unlike earlier reports 19 we did not find altruism to be associated with uptake of BRCA testing. Our findings in the low-risk AJ population are consistent with some reports from high-risk clinics, 15, 16 and indicate that people initially coming forward for BRCA testing are better informed of its To make child-bearing decisions Somewhat important benefits, and rate these higher, while giving less consideration to limitations/risks. Our results suggest education and counselling in an unselected Jewish population leads to increased awareness of disadvantages of BRCA testing which influences the final cost-benefit perception and choices people make. 15, 16, 18 The high level of initial 'interest' in BRCA testing seen in our participants is consistent with self-referral. It has also been reflected in recruitment to the Israeli/Canadian studies and reported in earlier smaller studies of varying ascertainment. [25] [26] [27] However, only 60% of participants indicated a clear intention to undergo testing before counselling. That 88% of attendees eventually consented to genetic testing suggests that BRCA testing may be acceptable to a large proportion of the AJ population and reflects the impact of pre-test education/counselling on informed decision-making. Most of the 40% who had not thought about/would not consider/were still considering BRCA1/2 testing opted to proceed with testing.
The items used by us for evaluating benefits/risks/cultural influences (attitude) towards BRCA testing have been adapted from items previously described and used by others in high-risk populations, 15, 16, 19, 20 and appear reliable and reproducible in a lower-risk population unselected for FH. The gender-based differences in attitude are an interesting finding and explain why 30% more women came forward for testing compared with men. Limited data exist on differences between men and women towards BRCA1/2 testing. The main predictors reported for men include need to know about children's risk and influence of women/other carriers in the family. [28] [29] [30] Men have been stated to be less likely than women to alter screening practices, require support or experience a changed psychological state. 31 Any populationscreening programme will need to better understand and address the concerns of men. We found attitudinal factors were independent of FH of cancer. A positive correlation of attitude with knowledge 15 and FH 15 as well as an inverse 18 correlation with FH has been previously reported. The mean age (53.8 years) of study participants was slightly older and probably reflects the age distribution of individuals proactively coming forward for testing in the study (self-referralbased recruitment), greater awareness of these issues at older ages, the significantly older age of the Jewish population compared with the non-Jewish population in the UK (44 versus 38 years for women and 41 versus 36 years for men), 32 as well as the likelihood that older individuals are more likely to be married (a factor significantly associated with uptake of testing). Nevertheless, study participants had a broad range of ages ranging from 18 to 88 years, with 12% being <35 years and 21% <40 years. Our analyses are adjusted for age of participants and we did not find age to affect interest/intention/uptake or overall attitude towards BRCA testing. *Omitted due to collinearity.
Our finding that individuals who were married/cohabiting were more likely to undergo BRCA testing could partly reflect the importance of genetic testing on marriage ability in Jewish communities and impact of our highlighting this issue at counselling prior to decisionmaking. Baseline knowledge showed a significant association with final uptake as well as initial interest/intention for BRCA testing. Baseline knowledge of volunteers in our study is higher than earlier reports. 18, 33 This may reflect increasing public awareness and easier access to information on genes, cancer risk, and genetic testing over the last decade. Higher levels of education are linked to increased concern regarding genetic-discrimination and may explain our findings of an inverse association with BRCA testing. 17 Our findings are consistent with earlier reports which found education 25 to be inversely correlated, knowledge 15 to be positively correlated, and FH or age to lack correlation 19, 33 with intention-to-test. However, a positive correlation with FH 15, 18 and none with education 19 has also been reported. The decision to undergo genetic testing falls under the category of health decisions where there is no single paramount choice but the decision needs to be individualised depending on how the person values benefits/harms of the intervention. This can be complex, potentially difficult, and dependent on numerous factors. Each factor has benefits and risks that people may value differently. It is important that individuals reflect on positive/negative consequences for informed decision-making 34, 35 based on their values/opinions. We found pre-test counselling in a low-risk population helped participants to weigh up the consequences of testing and enabled informed decisionmaking. Recent Canadian 3, 6 and Israeli 36 single-arm population-based studies provided post-test counselling but not pre-test counselling. Reports from the Canadian study suggest 58.5% women who tested positive and 19% overall would have preferred the opportunity to have had pre-test counselling. 6 Nevertheless, both 'pre-test' and 'post-test only' counselling approaches explored in all three population studies report similar and extremely high levels of overall satisfaction (91-95%) with the testing process. Earlier randomised trials found standard face-toface pre-test counselling comparable with pre-test telephone, DVD-based, and tele-genetic counselling. 4, [37] [38] [39] [40] The changing landscape, increasing awareness, and expanding applicability enabling large-scale high-volume genetic testing has resulted in exploration of novel approaches with a move away from traditional face-to-face counselling. A web-based decision-aid and telephone helpline approach for pre-test decision-making is being piloted in a pilot population-based panel-testing study (PROMISE feasibility study). 41 However, there are currently no randomised data comparing pre-test counselling with 'no pre-test' or 'only post-test' counselling. This remains an important area for future research.
Conclusion
BRCA testing is acceptable to a large proportion of AJ. Our findings show that a number of factors affecting BRCA testing in a low-risk AJ population are similar to those previously reported from high-risk clinics. These data would be of interest to planners of genetic services and any populationbased programme should this be instituted in the future. Pre-test counselling in the population-testing setting also facilitates informed decision-making on BRCA testing. Further research is needed to robustly compare pre-test counselling (current standard-of-care) with newer approaches such as pre-test decision-aids and/or helpline alone.
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